Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rocket Pharmaceuticals, Inc.

6.06
-0.5600-8.47%
Pre-market: 6.00-0.0550-0.91%08:04 EDT
Volume:2.41M
Turnover:14.85M
Market Cap:652.35M
PE:-2.32
High:6.95
Open:6.53
Low:5.90
Close:6.62
Loading ...

Bank of America Securities Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
02 Mar

When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit?

Simply Wall St.
·
02 Mar

Analysts Are Bullish on Top Healthcare Stocks: BioRestorative Therapies (BRTX), Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
02 Mar

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus

Zacks
·
01 Mar

Morgan Stanley Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
28 Feb

Rocket Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
28 Feb

Analysts Are Bullish on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT), Janux Therapeutics Inc (JANX)

TIPRANKS
·
28 Feb

Rocket Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Rocket Pharmaceuticals Q4 2024 GAAP EPS $(0.62) Beats $(0.71) Estimate

Benzinga
·
28 Feb

Rocket Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance
·
28 Feb

Rocket Pharmaceuticals: Expects Cash Resources Sufficient to Fund Operations Into Q3 2026

THOMSON REUTERS
·
28 Feb

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress

Business Wire
·
28 Feb

Selling Rocket Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders

Simply Wall St.
·
26 Feb

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), CareDx (CDNA) and Intellia Therapeutics (NTLA)

TIPRANKS
·
14 Jan

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live
·
31 Dec 2024

Rocket Pharmaceuticals' Continued Pipeline Development to Support Long-Term Growth Potential, Wedbush Says

MT Newswires Live
·
31 Dec 2024

Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’

TIPRANKS
·
30 Dec 2024

Rocket Pharmaceuticals initiated with an Outperform at Wedbush

TIPRANKS
·
30 Dec 2024

Wedbush Initiates Rocket Pharmaceuticals at Outperform With $32 Price Target

MT Newswires Live
·
30 Dec 2024

Rocket Pharmaceuticals Inc : Wedbush Initiates Coverage With Outperform Rating; Price Target $32

THOMSON REUTERS
·
30 Dec 2024